Viva Biotech Investor
Viva Biotech offers global innovative drug R&D companies one-stop comprehensive services ranging from early structure-based drug R&D to commercial drug delivery. Using its advantages in the field of structure-based drug discovery (SBDD) technology, it provides global partners with CRO services in the new drug research stage and has established X-ray protein crystal technology, cryo-electron microscopy (Cryo-EM), and affinity mass spectrometry screening technology (ASMS), surface plasmon resonance (SPR), hydrogen-deuterium exchange mass spectrometry (HDX-MS), computer-aided drug design, and other advanced technology platforms.
Headquarters:
Shanghai,Shanghai,China,Asia
Industry:
Regenerative Medicine
Number Of Exists:
2
Investor Type:
Venture Funds
Founded Date:
2008-01-01
Funding Status:
public